Oscar Health (NYSE:OSCR) Insider Sells 38,835 Shares

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 38,835 shares of the business’s stock in a transaction on Wednesday, December 24th. The shares were sold at an average price of $15.00, for a total transaction of $582,525.00. Following the completion of the transaction, the insider owned 438,348 shares in the company, valued at approximately $6,575,220. The trade was a 8.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Mario Schlosser also recently made the following trade(s):

• On Tuesday, December 2nd, Mario Schlosser sold 23,965 shares of Oscar Health stock. The shares were sold at an average price of $16.59, for a total value of $397,579.35.
• On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14.

Oscar Health Stock Down 0.2%

Shares of Oscar Health stock traded down $0.03 during trading on Tuesday, reaching $14.50. 4,909,284 shares of the company traded hands, compared to its average volume of 14,119,056. The firm has a market capitalization of $3.84 billion, a PE ratio of -12.94 and a beta of 1.88. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80. The company has a 50 day moving average price of $16.46 and a 200-day moving average price of $17.07. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating the consensus estimate of ($0.55) by $0.02. The company had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The firm’s revenue for the quarter was up 23.2% compared to the same quarter last year. During the same period last year, the business posted ($0.22) EPS. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of the company. LRI Investments LLC boosted its stake in Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after acquiring an additional 975 shares in the last quarter. Farther Finance Advisors LLC raised its stake in shares of Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock worth $25,000 after purchasing an additional 1,282 shares during the last quarter. Atlantic Union Bankshares Corp bought a new position in shares of Oscar Health during the second quarter valued at $33,000. Quarry LP boosted its holdings in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after acquiring an additional 1,469 shares during the last quarter. Finally, Tsfg LLC purchased a new stake in Oscar Health during the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on OSCR shares. Wall Street Zen downgraded shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Piper Sandler raised Oscar Health from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $13.00 to $25.00 in a report on Tuesday, November 25th. Barclays boosted their target price on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research note on Monday, November 10th. Finally, Stephens initiated coverage on Oscar Health in a report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price target for the company. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $15.57.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.